Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
European Journal of Medicinal Chemistry
|
August 10, 2018
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases
Cyril Fersing, Clotilde Boudot, Julien Pedron, et al.
Journal of Medicinal Chemistry
|
October 12, 2025
Use of P450 Enzymes for Late-Stage Functionalization in Drug Discovery
Vincent Poon, Christopher Bailey, Sandra Carvalho, et al.
ACS Infectious Diseases
|
June 25, 2026
Using Unbiased Chemical Proteomics Approaches to Explore the Target Landscape of the Resistance Refractory 7-Azaindole MMV022224 in <i><i>Plasmodium falciparum</i></i>
Aisha J Syed, Rachel Milne, Victoriano Corpas-Lopez, et al.
ACS Infectious Diseases
|
October 3, 2017
Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani
Leah S Torrie, Stephen Brand, David A Robinson, et al.
ACS Infectious Diseases
|
January 23, 2020
The Q<sub>i</sub> Site of Cytochrome <i>b</i> is a Promiscuous Drug Target in <i>Trypanosoma cruzi</i> and <i>Leishmania donovani</i>
Richard J Wall, Sandra Carvalho, Rachel Milne, et al.
Journal of Medicinal Chemistry
|
October 29, 2021
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
Charles E Mowbray, Stéphanie Braillard, Paul A Glossop, et al.
ACS Infectious Diseases
|
November 2, 2018
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
Victoriano Corpas-Lopez, Sonia Moniz, Michael Thomas, et al.
ACS Infectious Diseases
|
September 15, 2021
Prioritization of Molecular Targets for Antimalarial Drug Discovery
Barbara Forte, Sabine Ottilie, Andrew Plater, et al.
Journal of Medicinal Chemistry
|
July 15, 2020
Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent <i>In Vitro</i> Antileishmanial Activity: Initial SAR and Assessment of <i>In Vivo</i> Activity
Michael G Thomas, Manu De Rycker, Richard J Wall, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-<i>a</i>]pyridines Are NTR1 Substrates That Display Potent <i>in Vitro</i> Antileishmanial Activity
Cyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
European Journal of Medicinal Chemistry
|
August 10, 2018
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases
Cyril Fersing, Clotilde Boudot, Julien Pedron, et al.
Journal of Medicinal Chemistry
|
October 12, 2025
Use of P450 Enzymes for Late-Stage Functionalization in Drug Discovery
Vincent Poon, Christopher Bailey, Sandra Carvalho, et al.
ACS Infectious Diseases
|
June 25, 2026
Using Unbiased Chemical Proteomics Approaches to Explore the Target Landscape of the Resistance Refractory 7-Azaindole MMV022224 in <i><i>Plasmodium falciparum</i></i>
Aisha J Syed, Rachel Milne, Victoriano Corpas-Lopez, et al.
ACS Infectious Diseases
|
October 3, 2017
Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani
Leah S Torrie, Stephen Brand, David A Robinson, et al.
ACS Infectious Diseases
|
January 23, 2020
The Q<sub>i</sub> Site of Cytochrome <i>b</i> is a Promiscuous Drug Target in <i>Trypanosoma cruzi</i> and <i>Leishmania donovani</i>
Richard J Wall, Sandra Carvalho, Rachel Milne, et al.
Journal of Medicinal Chemistry
|
October 29, 2021
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
Charles E Mowbray, Stéphanie Braillard, Paul A Glossop, et al.
ACS Infectious Diseases
|
November 2, 2018
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
Victoriano Corpas-Lopez, Sonia Moniz, Michael Thomas, et al.
ACS Infectious Diseases
|
September 15, 2021
Prioritization of Molecular Targets for Antimalarial Drug Discovery
Barbara Forte, Sabine Ottilie, Andrew Plater, et al.
Journal of Medicinal Chemistry
|
July 15, 2020
Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent <i>In Vitro</i> Antileishmanial Activity: Initial SAR and Assessment of <i>In Vivo</i> Activity
Michael G Thomas, Manu De Rycker, Richard J Wall, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-<i>a</i>]pyridines Are NTR1 Substrates That Display Potent <i>in Vitro</i> Antileishmanial Activity
Cyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
Page
of 10